Eugene, OR, United States of America

Janine North

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tersera Therapeutics LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Janine North. Retrieved from https://idiyas.com/inventor/janine-north

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Janine North: Inventor in Neuroendocrine Tumor Treatment.

Introduction

Janine North is an inventor associated with Eugene, Oregon, and Tersera Therapeutics LLC. Her patent work concerns treatment approaches intended to reduce the likelihood of carcinoid heart disease in patients with neuroendocrine tumors.

Latest Patents

North is associated with 1 patent, titled “Methods of Reducing the Likelihood of Carcinoid Heart Disease in Patients with Neuroendocrine Tumors.” The patent describes methods for treating patients with newly diagnosed neuroendocrine tumors, early signs of carcinoid heart disease without prior heart valve replacement, or a recent heart valve replacement. The described methods involve administering telotristat ethyl, with the aim of reducing the development of carcinoid heart disease and improving clinical outcomes.

Career Highlights

North’s listed patent reflects work focused on potential treatment strategies for people with neuroendocrine tumors and related cardiac complications. She is associated with Tersera Therapeutics LLC.

Collaborations

North’s listed coworker is Lonnie Brent. The available information identifies this professional connection but does not specify their roles or the nature of their collaboration.

Conclusion

Janine North’s patent work centers on the potential use of telotristat ethyl to address carcinoid heart disease risk and support clinical outcomes for patients with neuroendocrine tumors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…